Decentralized Clinical Trial (DCT)

Decentralized Clinical Trial (DCT)

  1. lut 28, 2025

What Does 'Decentralized Clinical Trial (DCT)’ Mean?

A Decentralized Clinical Trial (DCT) is a study model that leverages technology and remote processes to conduct research outside traditional clinical settings. DCTs allow participants to engage in trials from their homes or local healthcare facilities, reducing the need for frequent visits to centralized study sites.

This approach utilizes digital health technologies, telemedicine, and home health care services to collect data and monitor participants. DCTs aim to improve patient recruitment and retention by offering greater convenience and accessibility, particularly for individuals with mobility issues or those living in remote areas.

Why Is the 'Decentralized Clinical Trial (DCT)’ Important in Clinical Research?

Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by addressing key challenges in traditional trial methodologies. They offer potential solutions to issues such as slow patient recruitment, high dropout rates, and limited diversity in study populations, which have long hindered the efficiency and representativeness of clinical studies.

The importance of DCTs has been further highlighted by global events like the COVID-19 pandemic, which necessitated alternative approaches to conducting research. By embracing DCTs, the clinical research industry can enhance patient-centricity, improve data quality through continuous monitoring, and potentially accelerate the drug development process, leading to faster delivery of new treatments to patients.

Good Practices and Procedures

  1. Implement a robust, secure telemedicine platform for virtual consultations and remote data collection, ensuring compliance with data protection regulations.
  2. Develop standardized protocols for home health visits, including procedures for sample collection, vital sign measurements, and equipment calibration.
  3. Establish a centralized digital platform for real-time adverse event reporting and monitoring, with automated alerts for immediate investigator review.
  4. Create a comprehensive patient training program on the use of wearable devices and mobile applications, including troubleshooting guides and technical support.
  5. Design a flexible scheduling system that accommodates participants’ preferences while maintaining protocol adherence and data integrity.

Related Terms

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…